Literature DB >> 33782317

Increased 68Ga-FAPI Uptake in Chronic Cholecystitis and Degenerative Osteophyte.

Huipan Liu, Zan Chen1, Xiao Yang, Wenhui Fu, Yue Chen.   

Abstract

ABSTRACT: 68Ga-FAPI PET/CT has been used in the evaluation of a variety of malignancies. An increasing number of case studies on FAPI uptake in nonmalignant diseases is also gaining support and enthusiasm. We present a case of asymptomatic chronic cholecystitis and degenerative osteophyte detected incidentally by 68Ga-FAPI PET/CT.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID： 33782317     DOI： 10.1097/RLU.0000000000003621

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  4 in total

Review 1.  Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond.

Authors:  Mengting Li; Muhsin H Younis; Yongxue Zhang; Weibo Cai; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-31       Impact factor: 10.057

2.  Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis.

Authors:  Lukas Kessler; Justin Ferdinandus; Nader Hirmas; Fadi Zarrad; Michael Nader; David Kersting; Manuel Weber; Sandra Kazek; Miriam Sraieb; Rainer Hamacher; Katharina Lueckerath; Lale Umutlu; Wolfgang P Fendler; Christoph Rischpler
Journal:  J Nucl Med       Date:  2021-10-07       Impact factor: 11.082

3.  Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?

Authors:  Hessamoddin Roustaei; Zahra Kiamanesh; Emran Askari; Ramin Sadeghi; Kamran Aryana; Giorgio Treglia
Journal:  Contrast Media Mol Imaging       Date:  2022-02-22       Impact factor: 3.161

Review 4.  FAPI PET versus FDG PET, CT or MRI for Staging Pancreatic-, Gastric- and Cholangiocarcinoma: Systematic Review and Head-to-Head Comparisons of Diagnostic Performances.

Authors:  Sophie E M Veldhuijzen van Zanten; Kay J Pieterman; Bas P L Wijnhoven; Ilanah J Pruis; Bas Groot Koerkamp; Lydi M J W van Driel; Frederik A Verburg; Maarten G J Thomeer
Journal:  Diagnostics (Basel)       Date:  2022-08-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.